---
title: Explicyte vs TRiCBIO
slug_a: explicyte
slug_b: tricbio
site: cro
review_signal_gate: closed
canonical_path: /compare/explicyte/tricbio
---

# Explicyte vs TRiCBIO

Side-by-side profile data from each company listing on this directory.

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.

## TRiCBIO

- Profile: [/companies/tricbio](/companies/tricbio)

TRiCBIO — TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.

Services: 8. Modalities: 3. Indications: 4. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Biomarker Assays
- Flow Cytometry Services
- Translational Research

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology
- Immunology
- Rare Disease
- Gastroenterology

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)